ProShare Advisors LLC Sells 226,295 Shares of Colgate-Palmolive Company $CL

ProShare Advisors LLC decreased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 10.9% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,845,163 shares of the company’s stock after selling 226,295 shares during the quarter. ProShare Advisors LLC owned about 0.23% of Colgate-Palmolive worth $167,725,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Westside Investment Management Inc. lifted its stake in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares during the period. Saudi Central Bank acquired a new position in Colgate-Palmolive in the first quarter valued at approximately $29,000. Ransom Advisory Ltd acquired a new stake in shares of Colgate-Palmolive during the 1st quarter worth approximately $33,000. Y.D. More Investments Ltd acquired a new position in shares of Colgate-Palmolive during the 1st quarter valued at $37,000. Finally, Atticus Wealth Management LLC grew its holdings in Colgate-Palmolive by 156.8% in the second quarter. Atticus Wealth Management LLC now owns 488 shares of the company’s stock worth $44,000 after purchasing an additional 298 shares during the period. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $78.76 on Monday. The firm has a market capitalization of $63.48 billion, a P/E ratio of 22.12, a price-to-earnings-growth ratio of 4.44 and a beta of 0.35. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The business’s fifty day simple moving average is $79.73 and its 200 day simple moving average is $85.64.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. During the same period last year, the business posted $0.91 earnings per share. The business’s revenue for the quarter was up 1.9% on a year-over-year basis. As a group, analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio is currently 58.26%.

Analyst Ratings Changes

CL has been the subject of a number of research analyst reports. Morgan Stanley decreased their target price on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. UBS Group reduced their price objective on Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. Finally, Raymond James Financial decreased their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research note on Monday, October 20th. Nine analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $89.87.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.